CN101450065A - Powder for treating livestock and poultry mycoplasma infection - Google Patents

Powder for treating livestock and poultry mycoplasma infection Download PDF

Info

Publication number
CN101450065A
CN101450065A CNA2007101505605A CN200710150560A CN101450065A CN 101450065 A CN101450065 A CN 101450065A CN A2007101505605 A CNA2007101505605 A CN A2007101505605A CN 200710150560 A CN200710150560 A CN 200710150560A CN 101450065 A CN101450065 A CN 101450065A
Authority
CN
China
Prior art keywords
mycoplasma
powder
poultry
infection
adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007101505605A
Other languages
Chinese (zh)
Inventor
李旭东
鲍恩东
苏建东
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TIANJIN RINGPU BIOLOGICAL TECHNOLOGY GROUP Co Ltd
Original Assignee
TIANJIN RINGPU BIOLOGICAL TECHNOLOGY GROUP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TIANJIN RINGPU BIOLOGICAL TECHNOLOGY GROUP Co Ltd filed Critical TIANJIN RINGPU BIOLOGICAL TECHNOLOGY GROUP Co Ltd
Priority to CNA2007101505605A priority Critical patent/CN101450065A/en
Publication of CN101450065A publication Critical patent/CN101450065A/en
Pending legal-status Critical Current

Links

Abstract

The invention relates to a powder agent for treating livestock and poultry mycoplasma infection, comprising tylosin tartrate, sulfadimidine sodium and auxiliary materials. The medicament of the invention can be mainly used for preventing and treating the mycoplasma disease of the livestock and poultry, meanwhile the sulfadimidine sodium is added in the preparation for controlling the secondary infection mixed infection caused by the mycoplasma, the medicament has good oral administration absorption effect and high safety, can be suitable for popularization and application in the animal production.

Description

A kind of powder that is used for the treatment of livestock and poultry mycoplasma infection
Technical field
The invention belongs to field of veterinary, particularly relate to a kind of powder that is used for the treatment of livestock and poultry mycoplasma infection.
Background technology
The mycoplasma disease is the normal a kind of diseases suffered from of poultry, and especially the mycoplasma with pig is comparatively serious.The porcine respiratory disease that is caused by mycoplasma is a kind of contact, chronic respiratory tract disease, is widely current in China.The pig of different sexes, age, kind all can infect.In the past, this sick single infection is chronic process more, and main clinic symptoms is pig cough and asthma, and body temperature and appetite do not have significant change.Though this sick mortality rate is not high, because its popular popularity, chronicity and expendable, and make the pig growth retardation, bring heavy losses to pig industry.Now, normal and the multiple pathogen mixed infections such as PRRS virus, swine influenza virus, PRV (Pseudorabies virus), pig circular ring virus, PRCV (Porcine Respiratory Coronavirus) and bronchus septicemic bordetella bacilli of mycoplasma, the porcine mycoplasmal disease also is very easy to secondary infection haemophilus parasuis disease, pig lung plague, actinomyces bacillus pleuropneumoniae, swine eperythrozoonosis etc., causes disease pig mortality rate significantly to increase.Mycoplasma also often takes place in poultry, mainly shows as respiratory symptom, as tracheitis, airsacculitis etc.
Summary of the invention
Based on above-mentioned situation, the object of the present invention is to provide a kind of powder that is used for the treatment of livestock and poultry mycoplasma infection
The object of the present invention is achieved like this: represent to be respectively tylosin tartrate 2%-3% with percentage by weight, sulfadimidine sodium 2%-3%, adjuvant 94%-96%.
Described adjuvant comprises: anhydrous glucose, oral glucose etc. are preferably anhydrous glucose.
In order to obtain better effect, preferred ingredient is: tylosin tartrate 2.5%, sulfadimidine sodium 2.5%, adjuvant 95%.
The present invention can adopt the general process of industry, equipment preparation.The following method preparation of preferred employing comprises step:
Earlier tylosin tartrate, sulfadimidine sodium are pulverized with used adjuvant, pulverized back mistake 60 mesh sieves; The adjuvant of getting tylosin tartrate, sulfadimidine sodium and equivalent with equivalent progressively increase the dilution method dilution, mixes, mistake 60 order fine screens three times obtain mixture; With mixture and remaining adjuvant mix homogeneously, mixture is crossed 80 order fine screens three times, promptly.
Tylosin tartrate: belong to macrolide antibiotics, be mainly used in control pig, fowl mycoplasma, also can be used as the growth promoter of pig.
Sulfadimidine sodium: be sulfa drugs, can be used for responsive microbial infection, as the infection of mastitis, endometritis, respiratory tract and digestive tract sensitive organism.
In order to verify the therapeutic effect of medicine of the present invention, get medicine of the present invention and do the clinical efficacy test on pig farm, Jinghai county.Get the sick pig that suffers from mycoplasma pneumonia, add medicine of the present invention in drinking-water, add 1g in every premium on currency, freely drink, logotype 5 days was a course of treatment.After the course of treatment, most of sick pig is cured, and effective percentage reaches more than 90%.By clinical trial as can be seen, medicine of the present invention curative effect aspect the treatment livestock and poultry mycoplasma infection is certain, is suitable for applying in herding is produced.
Beneficial effect: the present invention fills a prescription and adopts tylosin tartrate and two kinds of compatibility of drugss of sulfadimidine sodium to use, be mainly used in the mycoplasma of control poultry, in prescription, add simultaneously sulfadimidine sodium, secondary infection and mixed infection that the control mycoplasma causes, oral absorption is good, has higher safety.
The specific embodiment
Embodiment 1: earlier tylosin tartrate 20g, sulfadimidine sodium 20g and used adjuvant anhydrous glucose 960g are pulverized, pulverize back mistake 60 mesh sieves; The adjuvant of getting tylosin tartrate, sulfadimidine sodium and equivalent with equivalent progressively increase the dilution method dilution, mixes, mistake 60 order fine screens three times obtain mixture; With mixture and remaining adjuvant mix homogeneously, mixture is crossed 80 order fine screens three times, promptly get the about 1000g of powder, wherein contain tylosin tartrate 20g, sulfadimidine sodium 20g.
Be mainly used in the mycoplasma of control poultry, also can be used for preventing and treating responsive microbial secondary infection and mixed infection etc. simultaneously.Usage and dosage: mix drink: add medicine 1.2g of the present invention in per 1 premium on currency, logotype 3-5 days is a course of treatment.
Embodiment 2: earlier tylosin tartrate 25g, sulfadimidine sodium 25g and used adjuvant oral glucose 950g are pulverized, pulverize back mistake 60 mesh sieves; The adjuvant of getting tylosin tartrate, sulfadimidine sodium and equivalent with equivalent progressively increase the dilution method dilution, mixes, mistake 60 order fine screens three times obtain mixture; With mixture and remaining adjuvant mix homogeneously, mixture is crossed 80 order fine screens three times, promptly get the about 1000g of powder, wherein contain tylosin tartrate 25g, sulfadimidine sodium 25g.
Be mainly used in the mycoplasma of control poultry, also can be used for preventing and treating responsive microbial secondary infection and mixed infection etc. simultaneously.Usage and dosage: mix drink: add medicine 1g of the present invention in per 1 premium on currency, logotype 3-5 days is a course of treatment.
Embodiment 3: earlier tylosin tartrate 30g, sulfadimidine sodium 30g and used adjuvant maize cob meal 940g are pulverized, pulverize back mistake 60 mesh sieves; The adjuvant of getting tylosin tartrate, sulfadimidine sodium and equivalent with equivalent progressively increase the dilution method dilution, mixes, mistake 60 order fine screens three times obtain mixture; With mixture and remaining adjuvant mix homogeneously, mixture is crossed 80 order fine screens three times, promptly get the about 1000g of powder, wherein contain tylosin tartrate 30g, sulfadimidine sodium 30g.
Be mainly used in the mycoplasma of control poultry, also can be used for preventing and treating responsive microbial secondary infection and mixed infection etc. simultaneously.Usage and dosage: mix drink: add medicine 0.8g of the present invention in per 1 premium on currency, logotype 3-5 days is a course of treatment.

Claims (3)

1, a kind of powder that is used for the treatment of livestock and poultry mycoplasma infection is characterized in that the medicine that this powder comprises is: tylosin tartrate, sulfadimidine sodium and adjuvant.
2, a kind of powder that is used for the treatment of livestock and poultry mycoplasma infection according to claim 1, it is characterized in that: represent to be respectively tylosin tartrate 2%-3% with percentage by weight, sulfadimidine sodium 2%-3%, adjuvant 94%-96%, described adjuvant comprises: anhydrous glucose, oral glucose etc. are preferably anhydrous glucose.
3, a kind of powder that is used for the treatment of livestock and poultry mycoplasma infection according to claim 1, it is characterized in that: preferred ingredient is: tylosin tartrate 2.5%, sulfadimidine sodium 2.5%, adjuvant 95%.
CNA2007101505605A 2007-11-29 2007-11-29 Powder for treating livestock and poultry mycoplasma infection Pending CN101450065A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2007101505605A CN101450065A (en) 2007-11-29 2007-11-29 Powder for treating livestock and poultry mycoplasma infection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2007101505605A CN101450065A (en) 2007-11-29 2007-11-29 Powder for treating livestock and poultry mycoplasma infection

Publications (1)

Publication Number Publication Date
CN101450065A true CN101450065A (en) 2009-06-10

Family

ID=40732663

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007101505605A Pending CN101450065A (en) 2007-11-29 2007-11-29 Powder for treating livestock and poultry mycoplasma infection

Country Status (1)

Country Link
CN (1) CN101450065A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102168073A (en) * 2010-11-30 2011-08-31 瑞普(保定)生物药业有限公司 Method for improving proliferation capability of mycoplasma gallisepticum in vaccine production
CN102406613A (en) * 2011-09-30 2012-04-11 上海恒丰强动物药业有限公司 Super tylosin soluble powder and preparation method thereof
CN103271931A (en) * 2013-05-20 2013-09-04 广东大华农动物保健品股份有限公司 Compound acetylisovalery tylosin tartrate pellet and preparation method thereof
CN106902082A (en) * 2017-03-03 2017-06-30 安徽安丰堂动物药业有限公司 A kind of tylosin tartrate soluble powder compound method for birds

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102168073A (en) * 2010-11-30 2011-08-31 瑞普(保定)生物药业有限公司 Method for improving proliferation capability of mycoplasma gallisepticum in vaccine production
CN102168073B (en) * 2010-11-30 2013-03-20 瑞普(保定)生物药业有限公司 Method for improving proliferation capability of mycoplasma gallisepticum in vaccine production
CN102406613A (en) * 2011-09-30 2012-04-11 上海恒丰强动物药业有限公司 Super tylosin soluble powder and preparation method thereof
CN102406613B (en) * 2011-09-30 2016-08-03 上海恒丰强动物药业有限公司 Super tylosin soluble powder and preparation method thereof
CN103271931A (en) * 2013-05-20 2013-09-04 广东大华农动物保健品股份有限公司 Compound acetylisovalery tylosin tartrate pellet and preparation method thereof
CN103271931B (en) * 2013-05-20 2015-04-22 广东大华农动物保健品股份有限公司 Compound acetylisovalery tylosin tartrate pellet and preparation method thereof
CN106902082A (en) * 2017-03-03 2017-06-30 安徽安丰堂动物药业有限公司 A kind of tylosin tartrate soluble powder compound method for birds

Similar Documents

Publication Publication Date Title
CN101543601B (en) Compound pharmaceutical composition for preventing and curing respiratory diseases in animals and preparation method thereof
CN103768026B (en) Water-soluble micro-powder containing amoxicillin and preparation method thereof
CN101468032A (en) Soluble powder for treating respiratory illness of livestock and poultry
CN101450065A (en) Powder for treating livestock and poultry mycoplasma infection
CN101496811B (en) Soluble and stable tilmicosin composition
CN103536536B (en) Wettability solid dispersing powder of florfenicol composition and preparation method thereof
CN103054833A (en) A formula of an antimicrobial oil emulsion microcapsule for veterinary use
CN101450069A (en) Soluble powder for treating poultry respiratory infection
CN101966178A (en) Composition for treating chicken proventriculitis and preparation method thereof
CN104586875A (en) Preparation method for compound tilmicosin enteric-coated granules
CN103169652B (en) Veterinary alkaline lincomycin injection as well as preparation method and use thereof
CN103417571A (en) Composition for treating chicken mycoplasma respiratory infection and preparing method thereof
CN110917141A (en) Method for preparing florfenicol soluble powder medicament
CN102379920B (en) Veterinary antiviral and antifebrile drug composition
CN101433518A (en) Compound ofloxacin injection for animals
CN104784411A (en) Pig respiratory tract diseases prevention and treatment drug composition, premix and matching material thereof
CN103550226B (en) Compound sulfamonomethoxine sodium injection as well as preparation method thereof
CN102755342B (en) Compound paracetamol injection and preparation method thereof
CN106362159A (en) Molecular skeleton type tilmicosin sustained release preparation and preparation method thereof
CN104473958A (en) Compound premix and preparation method and application thereof
CN101612154A (en) Contain the compositions of pivampicillin and preparation method, purposes
CN101301274B (en) Compound mequindox soluble powder for animals and preparation thereof
CN108653228B (en) Skeleton type sustained-release doramectin tablet and preparation method thereof
CN105031025B (en) Compound Chinese medicinal preparation for treating porcine mycoplasmal pneumonia and preparation method thereof
CN101450066A (en) Soluble powder for treating poultry bacterial and mycoplasma infection

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090610